Karyopharm Therapeutics | KPTI - Interest Income


Karyopharm Therapeutics reported $-0.15 in Interest Income for its fiscal quarter ending in December of 2024.





Interest Income Change Date
AbbVie USD 59M 13M Dec/2025
Abbott USD 78M 1000K Dec/2025
AstraZeneca USD 73M 62M Mar/2026
BioCryst Pharmaceuticals USD -0.13 3.59M Dec/2024
Eli Lilly USD 65M 25M Sep/2025
GlaxoSmithKline GBP 22M 96M Mar/2026
Incyte USD 33.69M 2.93M Mar/2026
J&J USD 2.14 237M Mar/2026
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024
MacroGenics USD 1.53M 114K Sep/2025
Merck USD 69M 27M Dec/2025
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Pfizer USD 115M 51M Mar/2026
Regeneron Pharmaceuticals USD 193.3M 18.2M Dec/2025
Takeda JPY 87.87B 43.48B Dec/2025
Tectonic Therapeutic USD 1.74M 217K Dec/2024
Ultragenyx Pharmaceutical USD 6.51M 649K Dec/2025
Xencor USD 6.2M 338K Dec/2025